If you manage a chronic condition like hypertension, type 2 diabetes, or weight, and you take medication for it, from blood pressure prescriptions to newer GLP-1 options, here is a question worth asking yourself this fall: is your current dose still doing the job it was doing a year ago?

Bodies change. Weight shifts, kidney and liver function can change with age, other medications get added or dropped, and even stress and sleep patterns affect how well a drug works for you. A dose that controlled your blood pressure or blood sugar last year may not be hitting the same mark today, and it is easy not to notice, especially if you have not had a check-in with your provider in a while.

This is exactly why groups like the American Heart Association have called for regular medication reviews to be a standard part of care, particularly for people managing more than one chronic condition at once. Deprescribing is described as a proactive, patient-centered strategy meant to reduce medication burden, useful not only after a bad reaction but whenever changing health circumstances call for a fresh look at what someone is taking.

The GLP-1 Factor

GLP-1 medication and blood pressure monitor

GLP-1 medications affect more than weight.

This is especially true for anyone on a GLP-1 medication for weight or blood sugar management. These medications do more than help with weight. Research has found that GLP-1 medications also produce modest reductions in blood pressure, typically in the range of 2 to 5 points systolic, across people with diabetes, obesity, or elevated cardiovascular risk, and that this effect comes mainly from the weight loss itself, along with some additional effects on blood vessel function.

In some clinical trials, the effect has been even larger. One major trial found that semaglutide led to significant drops in both systolic and diastolic blood pressure alongside substantial weight loss.

If you started a GLP-1 medication and have lost meaningful weight, your blood pressure medications may now be doing more than they need to, or even causing readings that run too low.

What this means in practice: if you started a GLP-1 medication and have lost a meaningful amount of weight since then, your blood pressure or blood sugar levels may have genuinely improved. That can mean your other prescriptions may now be doing more than they need to. This is not something to adjust on your own. It is something to bring to your provider.

Pharmacist consulting with patient

Your pharmacist is one of the most underutilized resources in your healthcare team.

Signs It Might Be Time for a Conversation

None of this means something is wrong. It means your body keeps changing, and your care should keep pace with it. If it has been a while, back to school season is as good a nudge as any to put a provider visit on your own calendar too.

Sources

American Heart Association. Deprescribing in patients with cardiovascular disease experiencing polypharmacy. Circulation, July 2026. professional.heart.org

GLP-1 receptor agonists and blood pressure: A state-of-the-art review. American Journal of Hypertension, 2026. academic.oup.com

GLP-1-based therapies for the treatment of resistant hypertension. eClinicalMedicine, The Lancet. pmc.ncbi.nlm.nih.gov